[1]SUN H, SAEEDI P, KARURANGA S, et al.IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 [J].Diabetes research and clinical practice, 2022, 183:109119-109119
[2]HE F, XIA X, WU X F, et al.Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis[J].Diabetologia, 2013, 56(3):457-466
[3]YAU J W, ROGERS S L, KAWASAKI R, et al.Global prevalence and major risk factors of diabetic retinopathy[J].Diabetes care, 2012, 35(3):556-564
[4] Bourne R. Alemayehu W. Arditi A..Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study[J].The Lancet Global health, 2021, 9(2):e144-e160
[5]Kai-Uwe E. Garabed E. Norbert L..KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease[J].American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007, 49((2 Suppl 2)): S12-154
[6]LI Y, SU X, YE Q, et al.The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies[J].Renal failure, 2021, 43(1):231-240
[7]CHEN H, ZHANG X, SHEN X.Ocular changes during hemodialysis in patients with end-stage renal disease[J].BMC ophthalmology, 2018, 18(1):208-208
[8]SUN G, HAO R, ZHANG L, et al.The effect of hemodialysis on ocular changes in patients with the end-stage renal disease[J].Renal failure, 2019, 41(1):629-635
[9]MULLAEM G, ROSNER M H.Ocular problems in the patient with end-stage renal disease[J].Seminars in dialysis, 2012, 25(4):403-407
[10]WANG W, LO A C Y.Diabetic Retinopathy: Pathophysiology and Treatments[J].International journal of molecular sciences, 2018, 19(6):1816-1816
[11]KIM E J, LIN W V, RODRIGUEZ S M, et al.Treatment of Diabetic Macular Edema[J].Current diabetes reports, 2019, 19(9):68-68
[12]KANG Q, YANG C.Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications[J].Redox biology, 2020, 37:101799-101799
[13]BEHL T, KAUR I, KOTWANI A.Implication of oxidative stress in progression of diabetic retinopathy[J].Survey of ophthalmology, 2016, 61(2):187-196
[14]CECILIA O M, JOSé ALBERTO C G, JOSé N P, et al.Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology [J].Journal of diabetes research, 2019, 2019:8562408-8562408
[15]MAHAJAN N, ARORA P, SANDHIR R.Perturbed Biochemical Pathways and Associated Oxidative Stress Lead to Vascular Dysfunctions in Diabetic Retinopathy [J].Oxidative medicine and cellular longevity, 2019, 2019: 8458472- 8458472
[16]TWARDA-CLAPA A, OLCZAK A, BIA?KOWSKA A M, et al.Advanced Glycation End-Products (AGEs): Formation,Chemistry,Classification,Receptors,and Diseases Related to AGEs[J].Cells, 2022, 11(8):1312-1312
[17]CEPAS V, COLLINO M, MAYO J C, et al.Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases[J].Antioxidants (Basel, Switzerland), 2020, 9(2):142-142
[18]ZONG H, WARD M, STITT A W.AGEs,RAGE,and diabetic retinopathy[J].Current diabetes reports, 2011, 11(4):244-252
[19]PENG J J, XIONG S Q, DING L X, et al.Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target[J].European journal of pharmacology, 2019, 853:381-387
[20]XU J, CHEN L J, YU J, et al.Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy[J].Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, 48(2):705-717
[21]WU M Y, YIANG G T, LAI T T, et al.The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy [J].Oxidative medicine and cellular longevity,, 2018, 2018:3420187-3420187
[22]LEWKO B, LATAWIEC E, MARYN A, et al.Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes [J].Experimental diabetes research,, 2011, 2011:278963-278963
[23]SAYESKI P P, KUDLOW J E.Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription[J].The Journal of biological chemistry, 1996, 271(25):15237-15243
[24]KOLM-LITTY V, SAUER U, NERLICH A, et al.High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells[J].The Journal of clinical investigation, 1998, 101(1):160-169
[25]DU X L, EDELSTEIN D, ROSSETTI L, et al.Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation[J].Proceedings of the National Academy of Sciences of the United States of America, 2000, 97(22):12222-12226
[26]GIACCO F, BROWNLEE M.Oxidative stress and diabetic complications[J].Circulation research, 2010, 107(9):1058-1070
[27]SHIBA T, INOGUCHI T, SPORTSMAN J R, et al.Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation[J].The American journal of physiology, 1993, 265(5 Pt 1):E783-793
[28]DERUBERTIS F R, CRAVEN P A.Activation of protein kinase C in glomerular cells in diabetesMechanisms and potential links to the pathogenesis of diabetic glomerulopathy[J].Diabetes, 1994, 43(1):1-8
[29]GERALDES P, HIRAOKA-YAMAMOTO J, MATSUMOTO M, et al.Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy[J].Nature medicine, 2009, 15(11):1298-1306
[30]HUANG H, HE J, JOHNSON D, et al.Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition[J].Diabetes, 2015, 64(1):200-212
[31]MITCHELL P, BANDELLO F, SCHMIDT-ERFURTH U, et al.The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema[J].Ophthalmology, 2011, 118(4):615-625
[32]BOSS J D, SINGH P K, PANDYA H K, et al.Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy[J].Investigative ophthalmology & visual science, 2017, 58(12):5594-5603
[33]ADAMIS A P, MILLER J W, BERNAL M T, et al.Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy[J].American journal of ophthalmology, 1994, 118(4):445-450
[34]HUNG C C, LIN H Y, HWANG D Y, et al.Diabetic Retinopathy and Clinical Parameters Favoring the Presence of Diabetic Nephropathy could Predict Renal Outcome in Patients with Diabetic Kidney Disease[J].Scientific reports, 2017, 7(1):1236-1236
[35]ZHANG J, WANG Y, LI L, et al.Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy[J].Renal failure, 2018, 40(1):243-251
[36]JENG C J, HSIEH Y T, YANG C M, et al.Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression[J].PloS one, 2016, 11(8):0161897-0161897
[37]WOLF G, MüLLER N, MANDECKA A, et al.Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus[J].Clinical nephrology, 2007, 68(2):81-86
[38]CHEN Y H, CHEN H S, TARNG D C.More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients[J].Diabetes care, 2012, 35(4):803-808
[39]GOPINATH M, N P R, HAFEEZ M, et al.To Study the Incidence of Diabetic Retinopathy in Different Stages of Diabetic Nephropathy in Type 2 Diabetes Mellitus[J].The Journal of the Association of Physicians of India, 2022, 70(4):11-12
[40]EL-MENYAR A, AL THANI H, HUSSEIN A, et al.Diabetic retinopathy: a new predictor in patients on regular hemodialysis[J].Current medical research and opinion, 2012, 28(6):999-1055
[41]DEVA R, ALIAS M A, COLVILLE D, et al.Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5[J].Clinical journal of the American Society of Nephrology : CJASN, 2011, 6(8):1866-1871
[42]WANG Y, GAO L.Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease[J].Frontiers in pharmacology, 2022, 13:800950-800950
[43]COLOMBO G, REGGIANI F, ASTORI E, et al.Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis[J].Free radical research, 2019, 53(11-12):1114-1124
[44]WITKO-SARSAT V, FRIEDLANDER M, CAPEILLèRE-BLANDIN C, et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J].Kidney international, 1996, 49(5):1304-1313
[45]LIAKOPOULOS V, ROUMELIOTIS S, GORNY X, et al.Oxidative Stress in Hemodialysis Patients: A Review of the Literature[J].Oxidative medicine and cellular longevity, 2017, 2017: 3081856- 3081856
[46]MILLER K, FORTUN J A.Diabetic Macular Edema: Current Understanding,Pharmacologic Treatment Options,and Developing Therapies[J].AsiaPacific journal of ophthalmology (Philadelphia, Pa), 2018, 7(1):28-35
[47]TOKUYAMA T, IKEDA T, SATO K.Effects of haemodialysis on diabetic macular leakage[J].The British journal of ophthalmology, 2000, 84(12):1397-1400
[48]FAN W, YUAN R D.Long-term hemodialysis improved and stabilized diabetic macular edema: two case reports[J].International journal of ophthalmology, 2021, 14(3):472-475
[49]SURYAKANTH S, SHANKAR H N R, HERALGI M M, et al.A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease[J].Taiwan journal of ophthalmology, 2021, 11(4):367-371
[50]KAMEDA Y, HANAI K, UCHIGATA Y, et al.Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis[J].Journal of diabetes investigation, 2020, 11(3):688-692
[51]MAIO T, LEMOS J, MOREIRA J, et al.Visual Impairment After Haemodialysis[J].Neuroophthalmology (Aeolus Press), 2019, 43(1):43-48
[52]SHEMESH A, MARGOLIN E.Sequential nonarteritic anterior ischemic optic neuropathy in patient on chronic hemodialysis[J].CEN case reports, 2019, 8(2):89-94
[53]MORROW M J.Ischemic Optic Neuropathy[J].Continuum (Minneapolis, Minn), 2019, 25(5):1215-1235
